Joan R Bloom, Susan L Stewart, Susan Chang, Myoungsoon You. Prev Med 2006
Times Cited: 21
Times Cited: 21
Times Cited
Times Co-cited
Similarity
Results of a randomized study of telephone versus in-person breast cancer risk counseling.
Almut W Helmes, Julie O Culver, Deborah J Bowen. Patient Educ Couns 2006
Almut W Helmes, Julie O Culver, Deborah J Bowen. Patient Educ Couns 2006
42
Effects of individualized breast cancer risk counseling: a randomized trial.
C Lerman, E Lustbader, B Rimer, M Daly, S Miller, C Sands, A Balshem. J Natl Cancer Inst 1995
C Lerman, E Lustbader, B Rimer, M Daly, S Miller, C Sands, A Balshem. J Natl Cancer Inst 1995
23
Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making.
Ellen T Matloff, Anne Moyer, Kristen M Shannon, Kristin B Niendorf, Nananda F Col. J Womens Health (Larchmt) 2006
Ellen T Matloff, Anne Moyer, Kristen M Shannon, Kristin B Niendorf, Nananda F Col. J Womens Health (Larchmt) 2006
23
Patients' resistance to risk information in genetic counseling for BRCA1/2.
Andrea D Gurmankin, Susan Domchek, Jill Stopfer, Christina Fels, Katrina Armstrong. Arch Intern Med 2005
Andrea D Gurmankin, Susan Domchek, Jill Stopfer, Christina Fels, Katrina Armstrong. Arch Intern Med 2005
23
Effects of a mammography decision-making intervention at 12 and 24 months.
Barbara K Rimer, Susan Halabi, Celette Sugg Skinner, Isaac M Lipkus, Tara S Strigo, Ellen B Kaplan, Gregory P Samsa. Am J Prev Med 2002
Barbara K Rimer, Susan Halabi, Celette Sugg Skinner, Isaac M Lipkus, Tara S Strigo, Ellen B Kaplan, Gregory P Samsa. Am J Prev Med 2002
23
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
23
Evaluation of a breast/ovarian cancer genetics referral screening tool in a mammography population.
Cecelia A Bellcross, Amy A Lemke, Laura S Pape, Angela L Tess, Lorraine T Meisner. Genet Med 2009
Cecelia A Bellcross, Amy A Lemke, Laura S Pape, Angela L Tess, Lorraine T Meisner. Genet Med 2009
23
A randomized trial of specialist genetic assessment: psychological impact on women at different levels of familial breast cancer risk.
K Brain, P Norman, J Gray, C Rogers, R Mansel, P Harper. Br J Cancer 2002
K Brain, P Norman, J Gray, C Rogers, R Mansel, P Harper. Br J Cancer 2002
19
A randomized trial of breast cancer risk counseling: interacting effects of counseling, educational level, and coping style.
C Lerman, M D Schwartz, S M Miller, M Daly, C Sands, B K Rimer. Health Psychol 1996
C Lerman, M D Schwartz, S M Miller, M Daly, C Sands, B K Rimer. Health Psychol 1996
19
Effects of a mail and telephone intervention on breast health behaviors.
Deborah J Bowen, Diane Powers. Health Educ Behav 2010
Deborah J Bowen, Diane Powers. Health Educ Behav 2010
20
Effects of risk counseling on interest in breast cancer genetic testing for lower risk women.
Deborah J Bowen, Wylie Burke, Yutaka Yasui, Anne McTiernan, Dale McLeran. Genet Med 2002
Deborah J Bowen, Wylie Burke, Yutaka Yasui, Anne McTiernan, Dale McLeran. Genet Med 2002
19
Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care.
Patricia Ashton-Prolla, Juliana Giacomazzi, Aishameriane V Schmidt, Fernanda L Roth, Edenir I Palmero, Luciane Kalakun, Ernestina S Aguiar, Susana M Moreira, Erica Batassini, Vanessa Belo-Reyes,[...]. BMC Cancer 2009
Patricia Ashton-Prolla, Juliana Giacomazzi, Aishameriane V Schmidt, Fernanda L Roth, Edenir I Palmero, Luciane Kalakun, Ernestina S Aguiar, Susana M Moreira, Erica Batassini, Vanessa Belo-Reyes,[...]. BMC Cancer 2009
19
Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics.
A C Antoniou, R Hardy, L Walker, D G Evans, A Shenton, R Eeles, S Shanley, G Pichert, L Izatt, S Rose,[...]. J Med Genet 2008
A C Antoniou, R Hardy, L Walker, D G Evans, A Shenton, R Eeles, S Shanley, G Pichert, L Izatt, S Rose,[...]. J Med Genet 2008
19
Subjective and objective risk of ovarian cancer in Ashkenazi Jewish women testing for BRCA1/2 mutations.
Kimberly M Kelly, Leigha Senter, Howard Leventhal, Gozde Ozakinci, Kyle Porter. Patient Educ Couns 2008
Kimberly M Kelly, Leigha Senter, Howard Leventhal, Gozde Ozakinci, Kyle Porter. Patient Educ Couns 2008
30
A preliminary validation of a family history assessment form to select women at risk for breast or ovarian cancer for referral to a genetics center.
C A Gilpin, N Carson, A G Hunter. Clin Genet 2000
C A Gilpin, N Carson, A G Hunter. Clin Genet 2000
19
Risk perception among women receiving genetic counseling: a population-based follow-up study.
Ellen M Mikkelsen, Lone Sunde, Christoffer Johansen, Søren P Johnsen. Cancer Detect Prev 2007
Ellen M Mikkelsen, Lone Sunde, Christoffer Johansen, Søren P Johnsen. Cancer Detect Prev 2007
28
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
19
A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes.
A C Antoniou, P D P Pharoah, G McMullan, N E Day, M R Stratton, J Peto, B J Ponder, D F Easton. Br J Cancer 2002
A C Antoniou, P D P Pharoah, G McMullan, N E Day, M R Stratton, J Peto, B J Ponder, D F Easton. Br J Cancer 2002
19
Does enhanced information at cancer genetic counseling improve counselees' knowledge, risk perception, satisfaction and negotiation of information to at-risk relatives?--a randomized study.
Afsaneh Hayat Roshanai, Richard Rosenquist, Claudia Lampic, Karin Nordin. Acta Oncol 2009
Afsaneh Hayat Roshanai, Richard Rosenquist, Claudia Lampic, Karin Nordin. Acta Oncol 2009
19
Development of a risk assessment tool for women with a family history of breast cancer.
Dejana Braithwaite, Stephen Sutton, James Mackay, Judith Stein, Jon Emery. Cancer Detect Prev 2005
Dejana Braithwaite, Stephen Sutton, James Mackay, Judith Stein, Jon Emery. Cancer Detect Prev 2005
19
The evolution of worry after breast cancer risk assessment: 6-year follow-up of the TRACE study cohort.
K Brain, E Parsons, P Bennett, R Cannings-John, K Hood. Psychooncology 2011
K Brain, E Parsons, P Bennett, R Cannings-John, K Hood. Psychooncology 2011
40
Longer-term influence of breast cancer genetic counseling on cognitions and distress: smaller benefits for affected versus unaffected women.
Arwen H Pieterse, Margreet G E M Ausems, Peter Spreeuwenberg, Sandra van Dulmen. Patient Educ Couns 2011
Arwen H Pieterse, Margreet G E M Ausems, Peter Spreeuwenberg, Sandra van Dulmen. Patient Educ Couns 2011
19
A systematic review of the impact of genetic counseling on risk perception accuracy.
Chris M R Smerecnik, Ilse Mesters, Eline Verweij, Nanne K de Vries, Hein de Vries. J Genet Couns 2009
Chris M R Smerecnik, Ilse Mesters, Eline Verweij, Nanne K de Vries, Hein de Vries. J Genet Couns 2009
19
Bilateral prophylactic mastectomy in women with inherited risk of breast cancer--prevalence of pain and discomfort, impact on sexuality, quality of life and feelings of regret two years after surgery.
Jessica Gahm, Marie Wickman, Yvonne Brandberg. Breast 2010
Jessica Gahm, Marie Wickman, Yvonne Brandberg. Breast 2010
19
Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.
Katrina Armstrong, Ellyn Micco, Amy Carney, Jill Stopfer, Mary Putt. JAMA 2005
Katrina Armstrong, Ellyn Micco, Amy Carney, Jill Stopfer, Mary Putt. JAMA 2005
19
Validity of models for predicting BRCA1 and BRCA2 mutations.
Giovanni Parmigiani, Sining Chen, Edwin S Iversen, Tara M Friebel, Dianne M Finkelstein, Hoda Anton-Culver, Argyrios Ziogas, Barbara L Weber, Andrea Eisen, Kathleen E Malone,[...]. Ann Intern Med 2007
Giovanni Parmigiani, Sining Chen, Edwin S Iversen, Tara M Friebel, Dianne M Finkelstein, Hoda Anton-Culver, Argyrios Ziogas, Barbara L Weber, Andrea Eisen, Kathleen E Malone,[...]. Ann Intern Med 2007
19
Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
Bernard Fisher, Joseph P Costantino, D Lawrence Wickerham, Reena S Cecchini, Walter M Cronin, Andre Robidoux, Therese B Bevers, Maureen T Kavanah, James N Atkins, Richard G Margolese,[...]. J Natl Cancer Inst 2005
Bernard Fisher, Joseph P Costantino, D Lawrence Wickerham, Reena S Cecchini, Walter M Cronin, Andre Robidoux, Therese B Bevers, Maureen T Kavanah, James N Atkins, Richard G Margolese,[...]. J Natl Cancer Inst 2005
19
Assessing BRCA carrier probabilities in extended families.
Carlos H Barcenas, G M Monawar Hosain, Banu Arun, Jihong Zong, Xiaojun Zhou, Jianfang Chen, Jill M Cortada, Gordon B Mills, Gail E Tomlinson, Alexander R Miller,[...]. J Clin Oncol 2006
Carlos H Barcenas, G M Monawar Hosain, Banu Arun, Jihong Zong, Xiaojun Zhou, Jianfang Chen, Jill M Cortada, Gordon B Mills, Gail E Tomlinson, Alexander R Miller,[...]. J Clin Oncol 2006
19
A randomised comparison of UK genetic risk counselling services for familial cancer: psychosocial outcomes.
P Hopwood, D Wonderling, M Watson, A Cull, F Douglas, T Cole, D Eccles, J Gray, V Murday, M Steel,[...]. Br J Cancer 2004
P Hopwood, D Wonderling, M Watson, A Cull, F Douglas, T Cole, D Eccles, J Gray, V Murday, M Steel,[...]. Br J Cancer 2004
20
19
The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation.
A Finch, K A Metcalfe, J K Chiang, L Elit, J McLaughlin, C Springate, R Demsky, J Murphy, B Rosen, S A Narod. Gynecol Oncol 2011
A Finch, K A Metcalfe, J K Chiang, L Elit, J McLaughlin, C Springate, R Demsky, J Murphy, B Rosen, S A Narod. Gynecol Oncol 2011
19
Factors associated with intrusive cancer-related worries in women undergoing cancer genetic risk assessment.
Paul Bennett, Clare Wilkinson, Jim Turner, Rhiannon Tudor Edwards, Barbara France, Gethin Griffith, Jonathon Gray. Fam Cancer 2009
Paul Bennett, Clare Wilkinson, Jim Turner, Rhiannon Tudor Edwards, Barbara France, Gethin Griffith, Jonathon Gray. Fam Cancer 2009
26
A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO.
D G R Evans, D M Eccles, N Rahman, K Young, M Bulman, E Amir, A Shenton, A Howell, F Lalloo. J Med Genet 2004
D G R Evans, D M Eccles, N Rahman, K Young, M Bulman, E Amir, A Shenton, A Howell, F Lalloo. J Med Genet 2004
19
A randomised controlled trial of breast cancer genetics services in South East Scotland: psychological impact.
A Fry, A Cull, S Appleton, R Rush, S Holloway, D Gorman, R Cetnarskyj, R Thomas, J Campbell, E Anderson,[...]. Br J Cancer 2003
A Fry, A Cull, S Appleton, R Rush, S Holloway, D Gorman, R Cetnarskyj, R Thomas, J Campbell, E Anderson,[...]. Br J Cancer 2003
19
Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study.
Yvonne Brandberg, Kerstin Sandelin, Staffan Erikson, Göran Jurell, Annelie Liljegren, Annika Lindblom, Ann Lindén, Anna von Wachenfeldt, Marie Wickman, Brita Arver. J Clin Oncol 2008
Yvonne Brandberg, Kerstin Sandelin, Staffan Erikson, Göran Jurell, Annelie Liljegren, Annika Lindblom, Ann Lindén, Anna von Wachenfeldt, Marie Wickman, Brita Arver. J Clin Oncol 2008
19
Selecting a BRCA risk assessment model for use in a familial cancer clinic.
Seema M Panchal, Marguerite Ennis, Sandra Canon, Louise J Bordeleau. BMC Med Genet 2008
Seema M Panchal, Marguerite Ennis, Sandra Canon, Louise J Bordeleau. BMC Med Genet 2008
19
Less correspondence between expectations before and cosmetic results after risk-reducing mastectomy in women who are mutation carriers: a prospective study.
Y Brandberg, B Arver, H Johansson, M Wickman, K Sandelin, A Liljegren. Eur J Surg Oncol 2012
Y Brandberg, B Arver, H Johansson, M Wickman, K Sandelin, A Liljegren. Eur J Surg Oncol 2012
19
Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.
L C Hartmann, D J Schaid, J E Woods, T P Crotty, J L Myers, P G Arnold, P M Petty, T A Sellers, J L Johnson, S K McDonnell,[...]. N Engl J Med 1999
L C Hartmann, D J Schaid, J E Woods, T P Crotty, J L Myers, P G Arnold, P M Petty, T A Sellers, J L Johnson, S K McDonnell,[...]. N Engl J Med 1999
19
Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
C Lerman, B Biesecker, J L Benkendorf, J Kerner, A Gomez-Caminero, C Hughes, M M Reed. J Natl Cancer Inst 1997
C Lerman, B Biesecker, J L Benkendorf, J Kerner, A Gomez-Caminero, C Hughes, M M Reed. J Natl Cancer Inst 1997
14
Pre-counseling education materials for BRCA testing: does tailoring make a difference?
Celette Sugg Skinner, Joellen M Schildkraut, Donald Berry, Brian Calingaert, P Kelly Marcom, Jeremy Sugarman, Eric P Winer, J Dirk Iglehart, P Andrew Futreal, Barbara K Rimer. Genet Test 2002
Celette Sugg Skinner, Joellen M Schildkraut, Donald Berry, Brian Calingaert, P Kelly Marcom, Jeremy Sugarman, Eric P Winer, J Dirk Iglehart, P Andrew Futreal, Barbara K Rimer. Genet Test 2002
14
Effects of colon cancer risk counseling for first-degree relatives.
Karen Glanz, Alana D Steffen, Lauren A Taglialatela. Cancer Epidemiol Biomarkers Prev 2007
Karen Glanz, Alana D Steffen, Lauren A Taglialatela. Cancer Epidemiol Biomarkers Prev 2007
14
Comparisons of tailored mammography interventions at two months postintervention.
Victoria L Champion, Celette Sugg Skinner, Usha Menon, Roopa Seshadri, Deborah C Anzalone, Susan M Rawl. Ann Behav Med 2002
Victoria L Champion, Celette Sugg Skinner, Usha Menon, Roopa Seshadri, Deborah C Anzalone, Susan M Rawl. Ann Behav Med 2002
14
Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement.
. Ann Intern Med 2005
. Ann Intern Med 2005
14
Application of BRCA1 and BRCA2 mutation carrier prediction models in breast and/or ovarian cancer families of French Canadian descent.
K K Oros, P Ghadirian, C M Maugard, C Perret, Y Paredes, A-M Mes-Masson, W D Foulkes, D Provencher, P N Tonin. Clin Genet 2006
K K Oros, P Ghadirian, C M Maugard, C Perret, Y Paredes, A-M Mes-Masson, W D Foulkes, D Provencher, P N Tonin. Clin Genet 2006
14
Effect of raloxifene on the incidence of invasive breast cancer in postmenopausal women with osteoporosis categorized by breast cancer risk.
Marc E Lippman, Steven R Cummings, Damon P Disch, John L Mershon, Sherie A Dowsett, Jane A Cauley, Silvana Martino. Clin Cancer Res 2006
Marc E Lippman, Steven R Cummings, Damon P Disch, John L Mershon, Sherie A Dowsett, Jane A Cauley, Silvana Martino. Clin Cancer Res 2006
14
Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.
B B Roa, A A Boyd, K Volcik, C S Richards. Nat Genet 1996
B B Roa, A A Boyd, K Volcik, C S Richards. Nat Genet 1996
14
Use of medications to reduce risk for primary breast cancer: a systematic review for the U.S. Preventive Services Task Force.
Heidi D Nelson, M E Beth Smith, Jessica C Griffin, Rongwei Fu. Ann Intern Med 2013
Heidi D Nelson, M E Beth Smith, Jessica C Griffin, Rongwei Fu. Ann Intern Med 2013
14
Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer.
J Peto, N Collins, R Barfoot, S Seal, W Warren, N Rahman, D F Easton, C Evans, J Deacon, M R Stratton. J Natl Cancer Inst 1999
J Peto, N Collins, R Barfoot, S Seal, W Warren, N Rahman, D F Easton, C Evans, J Deacon, M R Stratton. J Natl Cancer Inst 1999
14
Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial.
Trevor J Powles, Sue Ashley, Alwynne Tidy, Ian E Smith, Mitch Dowsett. J Natl Cancer Inst 2007
Trevor J Powles, Sue Ashley, Alwynne Tidy, Ian E Smith, Mitch Dowsett. J Natl Cancer Inst 2007
14
Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer.
Victor G Vogel, Joseph P Costantino, D Lawrence Wickerham, Walter M Cronin, Reena S Cecchini, James N Atkins, Therese B Bevers, Louis Fehrenbacher, Eduardo R Pajon, James L Wade,[...]. Cancer Prev Res (Phila) 2010
Victor G Vogel, Joseph P Costantino, D Lawrence Wickerham, Walter M Cronin, Reena S Cecchini, James N Atkins, Therese B Bevers, Louis Fehrenbacher, Eduardo R Pajon, James L Wade,[...]. Cancer Prev Res (Phila) 2010
14
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.